Can-Fite Reports Second Quarter 2020 Financial Results & Provides Clinical Update
PETACH TIKVA, Israel–(BUSINESS WIRE)–Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer, liver and inflammatory diseases, today announced financial results for the six months ended June 30, 2020. Clinical Developments and Corporate Highlights for the Second Quarter and Recent Weeks Include: Piclidenoson Phase…
Details